TLIS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Talis Biomedical Corp

Watchlist Manager

Watchlist

Price: 2.84 USD Market Closed

Market Cap: $5.2m

T	Talis Biomedical Corp NASDAQ:TLIS	US

Profitability Summary

Talis Biomedical Corp's profitability score is 9/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

71%

Gross Margin is Increasing

-26% > 95%

Negative Operating Margin

-11 353%

Negative 3Y Average Operating Margin

-5 841%

Declining Operating Margin

-3 166% > -11 353%

Negative Net Margin

-12 506%

Negative 3Y Average Net Margin

-6 158%

Declining Net Margin

-3 009% > -12 506%

Negative Free Cash Flow Margin

-9 862%

Negative 3Y Average Free Cash Flow Margin

-4 837%

Declining Free Cash Flow Margin

-2 332% > -9 862%

Negative ROE

-70%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-307%

Declining ROIC

-242% > -295%

View All

Hide

Collapse

9 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.